Clinical conditions associated with COVID-19 affecting the central nervous system | No. of patients / Proportion |
Encephalopathy | 990 (60·7%) |
Unspecified stroke type | 416 (25·5%) |
Ischemic stroke | 159 (9·7%) |
Hemorrhagic stroke | 40 (2·4%) |
Encephalitis and meningoencephalitis | 19 (1·2%) |
Acute disseminated encephalomyelitis (ADEM) | 4 (0·2%) |
Venous sinus thrombosis | 3 (0·2%) |
Multiple sclerosis exacerbation | 2 (0·1%) |
Total | 1633 (100%) |
Clinical conditions associated with COVID-19 affecting the peripheral nervous system | No. of patients / Proportion |
Guillain-Barré syndrome | 22 (51·2%) |
Other cranial nerve disorders | 12 (27·9%) |
Facial palsy (Bell syndrome) | 5 (11·6%) |
Miller-Fisher syndrome and polyneuritis cranialis | 4 (9·3%) |
Total | 43 (100%) |